Bafna Pharmaceuticals Limited

NSE:BAFNAPH India Drug Manufacturers - Specialty & Generic

Market Cap

$29.86 Million

₹2.59 Billion INR

Market Cap Rank

#31901 Global

#1779 in India

Share Price

₹109.31

Change (1 day)

+4.99%

52-Week Range

₹72.00 - ₹192.44

All Time High

₹507.50

Bafna Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of September 2025: 1.07%

Bafna Pharmaceuticals Limited (BAFNAPH) has an Asset Resilience Ratio of 1.07% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

₹17.13 Million

Cash + Short-term Investments

Total Assets

₹1.61 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how Bafna Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Bafna Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₹0.00	0%
Short-term Investments	₹17.13 Million	1.07%
Total Liquid Assets	₹17.13 Million	1.07%

Asset Resilience Insights

Limited Liquidity: Bafna Pharmaceuticals Limited maintains only 1.07% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.